Boehringer Ingelheim Aims A Shot At India’s Booming OTC Market
This article was originally published in PharmAsia News
Executive Summary
The family-controlled German drug maker is preparing an entry into the Indian consumer health care segment, a market seeing a flurry of activity from its global competitors like GSK and Sanofi.